Benjamin Li
Mar 5, 2010

Mindshare, Aegis Media, OMD and ZenithOptimedia vie for Xian-Janssen Pharmaceutical media planning account in China

BEIJING - Johnson & Johnson owned Xian-Janssen Pharmaceutical Company has called a media planning review in China.

Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Johnson & Johnson Daktarin Xian-Janssen Pharmaceutical
Mindshare, Aegis Media, OMD and ZenithOptimedia are understood to be involved in the pitch.

According to agency sources, the account is a “good size and meaningful” and is worth an estimated US$15 million.

OMD holds the media buying account for Johnson & Johnson. The agency won the business in 2007, which also includes Shanghai Johnson & Johnson Pharmaceuticals and Johnson & Johnson Vision Care.

Motilium and Daktarin are among Xian-Janssen Pharmaceutical's main products in China.


 
Source:
Campaign China

Related Articles

Just Published

3 hours ago

Matt McNally returns to Publicis as global CEO of ...

McNally will be based in New York and report to Publicis Groupe CEO Arthur Sadoun.

23 hours ago

TikTok launches Messaging Ads in Asia Pacific

TikTok’s Messaging Ads are now available in Australia, Indonesia, Japan, Korea, Malaysia, New Zealand, Philippines, Thailand, Vietnam, and Singapore.

1 day ago

Creative Minds: Ya Wen believes creativity can ...

Get to know the visual designer at Tomato Interactive who approaches creativity beyond the next bright and shiny thing.

1 day ago

Creatives pick 2024 work they admire—and are jealous of

Creatives reveal their standout campaigns of 2024 that ignited both admiration and envy, and the lessons these works offer about branding, storytelling, and audience engagement.